Vladimir from Hungary

Zyprexa User Feedback

2007-07-16T13:54:00.000-07:00

Zyprexa User Feedback

The following is feedback from an actual Zyprexa user: The public has a right to know the truth and draw its own conclusions about Zyprexa and Eli Lilly's behavior. I know I am just a little old patient and that we are all supposed to go sit off in the corner and let big pharmaceuticals, the FDA, researchers, the American Psychiatric Association, the federal government and mental health advocates decide how the mental health game will be played, defined, advertised, spun, justified and otherwise ginned-up. However there are millions of patients who take Zyprexa--as well as other chemically-similar atypical antipsychotics--and they have an absolute right to know the truth about Zyprexa. There have been two dozen deaths associated with the use of Zyprexa.

Zyprexa Competition

2007-07-10T11:58:00.000-07:00

Zyprexa Competition

Over the last couple years, Zyprexa competitors have been making significant strides within the antipsychotic drug sales arena. Since 2005, Johnson & Johnson's Risperdal (risperidone) has become the most widely prescribed antipsychotic (growing its US sales by 36% in 2005). Also Pfizer's Geodon (ziprasidone) has experienced a 6% increase over the year-ago quarter with 32% annual growth, for the same year.

How Zyprexa Should Be Taken When Prescribed

2007-07-06T11:05:00.000-07:00

How Zyprexa Should Be Taken When Prescribed

It is recommended that Zyprexa be taken once a day, with or without food. To use Zyprexa, open the sachet, peel back the foil on the blister pack, remove the tablet and place the entire tablet in the mouth. It is recommended that you do not push the tablet through the foil. This particular medication can be taken with or without water. That's because the saliva in your mouth will cause the tablet to dissolve. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the one you missed and go back to your regular schedule. To avoid injury or side ! effects, do not take two doses of Zyprexa simultaneously.

The Future of Zyprexa

2007-07-05T11:58:00.000-07:00

The Future of Zyprexa

Over the last few years, dozens of new lawsuits have been filed by patients who say they took Zyprexa without knowing the risks. This, of course, was well after Eli Lilly promoted the drug to physicians, as a treatment for conditions other than mental illness (which is what Zyprexa was initially approved by the FDA to treat in the first place). In June of 2005, Eli Lilly announced plans to settle some 8,000 claims. These lawsuits were brought by patients who alleged they developed diabetes, as a result of their use of Zyprexa. Ironically, the company quickly settled the cases for 690 million dollars. This was after only five plaintiffs had provided depositions; and before any substantive depositions had even been taken from the Lilly defendants. However, even lawsuits don't appear to be deterring Eli Lilly from promoting Zyprexa. According to Lilly's SEC filing last year, sales of Zyprexa in the second quarter of 2006 totaled 1.12 billion dollars. This represented a 2% increase over the second quarter of 2005. Even so, the latest sales report regarding Zyprexa released by the company wasn't so up-beat. On July 4^th, 2007, chief executive officer of Eli Lilly, Sidney Taurel said Wednesday (because of lingering safety concerns) sales ! of its blockbuster psychiatric drug Zyprexa will largely be flat in 2007; when compared with 2006 sales.

Legal Actions Resulting from the Use of Zyprexa

2007-06-29T12:21:00.000-07:00

Legal Actions Resulting from the Use of Zyprexa

In April of 2007, the news couldn't have been much worse for drug manufacturer Eli Lilly. That's when a group of its very own share holders filed a class-action lawsuit against directors of the company. The share holders are alleging that Eli Lilly engaged in fraud and violated the Securities Exchange Act of 1934. All this supposedly occurred when Eli Lilly allegedly mislead consumers and investors, during their promotional campaign for their psychiatric drug known as Zyprexa.

In essence, the lawsuit alleges that Eli Lilly intentionally failed to disclose key material facts regarding the use of the drug. One of these key facts is that the share holders believe Eli Lilly intentionally hid the link between Zyprexa and the onset of diabetes and weight gain. Attorneys for the share holders also allege Eli Lilly engaged in a scheme to offset a drop in the sales of Zyprexa; after the drug's side effects were disclosed to the public. Another allegation is that Eli Lilly knew that the growth rate in sales would not and could not be sustained, if and when the public became aware of the adverse health issues associated with Zyprexa.

Sales of Zyprexa soared, between the years 2002 and 2004. Many prudent investors rode this gravy train into the station; cashing in at just the right time. However, other investors would not be so lucky. That's because in 2004, it was publicly disclosed that Zyprexa (among other things) was linked to diabetes and weight gain. As a devastating consequence of this revelationbetween May 7^th, 2004 and October 25^th, 2004share holders of Eli Lilly stock lost some 30 billion dollars. This was the direct result of a declination in th! e value of the company's stock (as well as the basis for this current class-action lawsuit).

Health Issues Associated with Zyprexa

2007-06-28T10:29:00.000-07:00

Health Issues Associated with the Use of Zyprexa

In 2005, the FDA issued a public health advisory to alert health care providers, patients and patient caregivers to safety information concerns. These concerns centered on the use of certain drugs called "atypical antipsychotic drugs." Zyprexa falls into this category. Although antipsychotics like Zyprexa were originally approved by the FDA for the treatment of schizophrenia and mania, these drugs are also used on elderly patients, in order to treat dementia. This health warning was issued afte! r clinical studies were conducted on these drugs. The findings were startling. They showed that elderly patients with dementia who were treated with antipsychotics have a higher death rate (when compared to patients who received a placebo).

The Side Effects of Zyprexa

2007-06-22T11:25:00.000-07:00

The Side Effects of Zyprexa

The side effects of taking Zyprexa can be numerous and varied. The patient's physician must be contacted immediately, if any of the following side effect symptoms occur: abdominal pain, rapid heartbeat, decrease in sexual desire, double vision, increased appetite, increased cough, increased sensitivity of the skin to sunlight, joint pain, low blood pressure, nausea, sore throat, stuttering, thirst, tightness of muscles, trouble in controlling urine, trouble in sleeping, vomiting, watering of mouth and weight loss. Some ! of the more common side effects of taking the drug are: agitation, behavior problems, difficulty in speaking or swallowing, restlessness, stiffness of arms or legs, trembling or shaking of the hands and fingers.

Some of the less common side effects are: chest pain, fever, flu-like symptoms, inability to move eyes, lip smacking or puckering, mood or mental changes (such as anger, anxiety, giddiness, loss of memory or nervousness), muscle spasms of the face, neck, and back, puffing of cheeks, rapid or worm-like movements of the tongue, swelling of the feet or ankles, twitching movements, uncontrolled chewing movements, uncontrolled movements of the arms and legs. The following side effect symptoms are considered to be rare: changes in menstrual period, confusion, mental or physical sluggishness, skin rash, swelling of the face and trouble breathing.

2007-06-20T18:16:00.000-07:00

More information soon but if you are researching legal issues visit zyprexa lawsuits.

The History of Zyprexa

2007-06-20T12:24:00.000-07:00

The History of Zyprexa

The pharmaceutical company Eli Lily developed the drug Olanzapine. Olanzapine received FDA approval in 1996. The company then began selling the drug, under the brand name of Zyprexa. By 2003, sales of Zyprexa reached a staggering 8 billion dollars. Approved as an atypical antipsychotic, Zyprexa is widely prescribed by clinicians a! round the world. Zyprexa is primarily used for the ongoing treatment of schizophrenia, acute manic episodes in bipolar disorder, acute agitation associated with schizophrenia and bipolar disorder. The drug is also used in the maintenance treatment of bipolar disorder. Zyprexa is also mixed with Fluoxetine and sold under the name Symbyax. When combined, these drugs are used to treat depressive episodes that are associated with bipolar disorder (as well as other mental illnesses).